We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Rush Enterprises Class B
RUSHB
$6.14B
| $444K | ﹤0.01% |
14,535
+198
| +1% | +$5.58K |
|
2602
Flywire
FLYW
$2.16B
| $443K | ﹤0.01% |
+10,101
| New | +$394K |
|
|
GATO
2603
DELISTED
Gatos Silver, Inc.
GATO
| $442K | ﹤0.01% |
37,972
+7,527
| +25% | +$105K |
|
2604
Atossa Therapeutics
ATOS
$23.5M
| $440K | ﹤0.01% |
8,999
+308
| +4% | +$17.9K |
|
2605
Funko
FNKO
$328M
| $440K | ﹤0.01% |
24,145
+1,213
| +5% | +$22.9K |
|
2606
First Bancorp
FNLC
$399M
| $439K | ﹤0.01% |
15,069
+289
| +2% | +$8.38K |
|
2607
VistaGen Therapeutics
VTGN
$12.8M
| $439K | ﹤0.01% |
5,342
+587
| +12% | +$51K |
|
2608
Willdan Group
WLDN
$1.3B
| $439K | ﹤0.01% |
12,335
+175
| +1% | +$6.59K |
|
2609
CEL-SCI Corp
CVM
$30.1M
| $438K | ﹤0.01% |
1,330
+46
| +4% | +$13.4K |
|
2610
Home Bancorp
HBCP
$566M
| $438K | ﹤0.01% |
11,313
+113
| +1% | +$4.2K |
|
2611
First Internet Bancorp
INBK
$255M
| $434K | ﹤0.01% |
13,926
-182
| -1% | -$5.5K |
|
|
PYCR
2612
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $433K | ﹤0.01% |
+12,301
| New | +$403K |
|
2613
Eos Energy Enterprises
EOSE
$1.51B
| $431K | ﹤0.01% |
30,751
+16,871
| +122% | +$250K |
|
|
GNTY
2614
DELISTED
Guaranty Bancshares
GNTY
| $431K | ﹤0.01% |
12,020
+231
| +2% | +$7.85K |
|
2615
Spyre Therapeutics
SYRE
$9.25B
| $430K | ﹤0.01% |
2,166
+59
| +3% | +$10.3K |
|
|
RRD
2616
DELISTED
RR Donnelley & Sons Co.
RRD
| $430K | ﹤0.01% |
83,666
+2,628
| +3% | +$14K |
|
2617
BlueLinx
BXC
$706M
| $426K | ﹤0.01% |
8,712
+415
| +5% | +$20.9K |
|
|
ZIXI
2618
DELISTED
Zix Corporation
ZIXI
| $426K | ﹤0.01% |
60,233
+2,091
| +4% | +$15.1K |
|
|
SMMF
2619
DELISTED
Summit Financial Group, Inc.
SMMF
| $424K | ﹤0.01% |
17,285
+27
| +0.2% | +$631 |
|
2620
Caribou Biosciences
CRBU
$164M
| $420K | ﹤0.01% |
+17,599
| New | +$430K |
|
2621
Safe Bulkers
SB
$774M
| $420K | ﹤0.01% |
81,248
+4,190
| +5% | +$16.2K |
|
2622
Blue Bird Corp
BLBD
$2.18B
| $419K | ﹤0.01% |
20,106
+517
| +3% | +$11.5K |
|
|
MRNS
2623
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $419K | ﹤0.01% |
36,782
+1,675
| +5% | +$23K |
|
|
PAE
2624
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $419K | ﹤0.01% |
69,996
+2,823
| +4% | +$21.6K |
|
2625
International Money Express
IMXI
$367M
| $418K | ﹤0.01% |
25,013
+1,810
| +8% | +$30.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.